FDA NDC Directory · JSON-LD · Markdown

Byetta

NDC 0310-6512 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameexenatide
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryNew Drug Application (innovator) · App NDA021773
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsEXENATIDE (250 ug/mL)
Marketing started20141210
Marketing ended20261231
Package count1

External sources

Source: openFDA. Public-domain (CC0).